Key facts
- This page summarizes Growth Equity Opportunities Fund IV, LLC's Form 4 filing for AVEO PHARMACEUTICALS, INC..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Oct 2022, 16:36.
Growth Equity Opportunities Fund IV, LLC - 19 Oct 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 19 Oct 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Louis Citron, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Growth Equity Opportunities Fund IV, LLC filed Form 4 for AVEO PHARMACEUTICALS, INC. on 21 Oct 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVEO
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -3,952,957
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Oct 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Growth Equity Opportunities Fund IV, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Growth Equity Opportunities Fund IV, LLC ("GEO IV") made a distribution of 3,952,957 shares of Common Stock of the Issuer to its sole member for no consideration on October 19, 2022.
Footnote F2
The Reporting Person previously over-reported one additional share of Common Stock of the Issuer due to rounding of fractional shares.
Footnote F3
The securities are directly held by GEO IV, and indirectly held by New Enterprise Associates 15, L.P. ("NEA 15"), the sole member of GEO IV, NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP (collectively, the "NEA 15 Managers"), together, the "GEO IV Indirect Reporting Persons"). The NEA 15 Managers are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell and Peter W. Sonsini. The GEO IV Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities in which the GEO IV Indirect Reporting Persons have no pecuniary interest.